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Abstract In order to study the cortisol-binding factors in blood, 
human plasma was applied to a ll/]-hydroxy-3-oxo-4-andro- 
stene-17~l-carboxyaminoethylamine-(HACA) 1,4-butanediol di- 
glycidyl ether-Sepharose column. Elution of the column with cor- 
tisol buffer produced two protein peaks, the minor peak yielded 
a protein complex of molecular weight ~200 kDa, subsequently 
termed hucolin. SDS-PAGE analysis under reducing and non- 
reducing conditions revealed hucolin was a disulphide-linked com- 
plex of 35-kDa and 75-kDa subunits. Twenty-five amino acid 
residues of the N-terminus of the 35-kDa subunit were determined 
and homology searches revealed an 88% sequence identity with 
the N-terminal region of ~-ficolin, a transforming growth factor- 
E1 (TGF-l~l)-binding protein purified from porcine uterus. 
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1. Introduction 
Cortisol, a naturally occurring lucocorticoid and its artifi- 
cial analogues, are powerful therapeutic agents used in the 
treatment of a large group of inflammatory diseases which 
include rheumatoid arthritis [1,2]. Corticosteroid-binding glob- 
ulin (CBG) binds >90% of cortisol in plasma nd regulates the 
levels of free cortisol [3,4]. In order to study other cortisol- 
binding proteins in human plasma these proteins were isolated 
from plasma by HACA-affinity chromatography, which em- 
ploys a derivative of corticosterone linked by a 13-atom spacer 
to Sepharose [5]. A novel corticosteroid-binding protein, subse- 
quently termed hucolin, was isolated and found to share a high 
degree of sequence homology and structural similarity with 
porcine ficolins. Ficolins are recently identified porcine trans- 
forming growth factor-]/(TGF-fll)-binding proteins, with fi- 
brinogen and collagen like domains [6]. TGF-fll is a member 
of a family of 25-kDa dimeric proteins, derived from platelets, 
and is a potent growth inhibitor of haemopoetic progenitor 
cells, lymphocytes, epithelial and endothelial cells. TGF-fll is 
also involved in wound healing and scarring and has been 
implicated in the pathogenesis of glomerulonephritis, liver cir- 
rhosis and pulmonary fibrosis [6,7,8]. 
2. Materials and methods 
Plasma was obtained as out-of-date fresh frozen plasma. Ultrafiltra- 
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tion units were from Amicon, MA, USA. Pre-stained molecular weight 
markers were from New England Biolabs, MA, USA and chemicals 
were obtained from Sigma Chemicals, UK. Problott PVDF membrane 
was obtained from Applied Biosystems CA, USA. 
Purification of hucolin was achieved, essentially by the method of 
Mickelson et al. [5], by the affinity chromatography of steroid-stripped 
plasma with 11,8-hydroxy-3-oxo-4-androstene- 17fl-carboxyaminoethyl- 
amine-l,4-butanediol diglycidyl ether-Sepharose as the resin [9]. 
Plasma (1 litre) was passed through a column (2.5 x 15.5 cm, of the 
affinity resin) at a flow rate of 150 ml/h at 4°C. The column was washed 
with 0.5 M KC1, 50 mM sodium phosphate, pH 9.0 buffer, at 4°C, until 
the UV absorbance ofthe washings was negligible (<0.01). The column 
was then placed at room temperature and, after 1 h, eluted with 0.1 M 
NaC1, 50 mM sodium phosphate buffer, pH 7.4, containing 280/lg/ml 
cortisol. The second, minor, protein peak was collected and concen- 
trated by ultrafiltration. 
Polyacrylamide g l electrophoresis employing 4% stacking and 9% 
resolving els in the presence of sodium dodecyl sulfate (SDS-PAGE) 
was performed according to the method of Laemmli [10]. 
Two-dimensional PAGE was accomplished byapplying protein to 
a well in the stacking el of a 9% SDS-PAGE gel and carrying out 
electrophoresis till the dye front was 5 mm from the end of the plates. 
The track containing protein was excised and soaked in a 50% (v/v) 
solution of stacking el buffer containing 2% (v/v) 2-mercaptoethanol 
and 0.33% (w/v) SDS for 45 min before washing the track, three times 
15 min, in soaking solution without 2-mercaptoethanol. Thestrip of 
polyacrylamide was then placed between two glass plates and a 9% 
resolving SDS polyacrylamide g l poured below it and a 4% stacking 
gel poured around it. Electrophoresis was carried out as described 
above and proteins transferred toPVDF membrane by electroblotting 
in 10% (v/v) methanol, 96 mM glycine, 12.5 mM Tris, pH 8.5, buffer 
at 30 V constant for 1.5 h [11]. The membrane was stained with 
Coomassie brilliant blue R-250 and protein spots cut out for N-terminal 
amino acid sequence determination. 
The PIR protein, SWISSPROT protein and EMBL DNA databases 
were searched for sequence homology using sequence strings generated 
by N-terminal sequence analysis and the BLAST search program avail- 
able at the world wide web address 'http://www.genome.ad.jp/SIT/ 
BLAST.htmI' on the Internet. 
3. Results 
Steroid-stripped human plasma was applied to the HACA- 
steroid Sepharose before washing extensively inhigh salt buffer 
to remove non-specifically bound plasma proteins. Specifically 
bound proteins were eluted by low salt buffer containing corti- 
sol. The elution profile exhibited one major and one minor 
protein peak (Fig. 1). Protein from the major peak contained 
mainly corticosteroid binding globulin. The minor peak was 
concentrated and resolved into 5 protein bands of molecular 
weights between 25 and 200 kDa, when separated by SDS- 
PAGE under non-reducing conditions (Fig. 2a). Under reduc- 
ing conditions the same sample resolved into four major bands 
and numerous minor bands, of molecular weights between 25 
and 80 kDa, indicating that some of the steroid binding proteins 
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Fig. 1. Elution profle of bound plasma proteins from HACA-Sepha- 
rose. The column was eluted with 280/tg/ml cortisol in 50 mM sodium 
phosphate, O.1 M NaC1 buffer pH 7.4, and fractions of 7.5 ml were 
collected. The minor protein peak, fractions 13-17, were pooled and 
concentrated. 
were disulphide-linked structures (results not shown). There- 
fore it was decided to characterise the proteins, in the minor 
elution peak, by separation in two dimensions: SDS-PAGE 
non-reducing in the first and reducing in the second before 
transferring proteins to PVDF membrane to determine their 
N-terminal amino acid sequence (Fig. 2b). 
Spot A2, MW 35 kDa (Fig. 2b), yielded the 25 amino acid 
sequence: LQAADTCPEVKMVGLEGSDKLTILR, and de- 
rived by reduction from band A, MW ~200 kDa (Fig. 2a). Spot 
D1, MW 35-kDa, yielded the identical but shorter sequence: 
LQAADTCPEVKMVGLEGSDK and derived by reduction 
from band D, MW 35-kDa (Fig. 2a). The 25 amino acid se- 
quence shared 88% identity with domestic pig (Scrofa domes- 
tica) il-ficolin and 80% with ~-ficolin, when protein databases 
were searched (Table 1). Spot A2 and D1 are, therefore likely 
to represent the same protein. 
Spot A1, MW 75 kDa (Fig. 2b), although faint, was consis- 
tently noted in each experiment and also derived by reduction 
from band A at -200 kDa (Fig. 2a). It yielded the six amino acid 
N-terminal sequence: AAFDDLQ. The initial N-terminal 
amino acid sequence yields for A1 and A2 were 6 and 68 pmol, 
respectively, which agree qualitatively with the relative staining 
intensities of the spots. Other spots were characterised aseither, 
CBG, albumin or CBG-IgG complexes, all of which bind corti- 
sol. 
These results suggest he protein, subsequently termed hu- 
colin (represented by band A; Fig. 2a), is a disulphide-linked 
multimeric protein which comprises predominately ficolin-like 
35-kDa subunits and a minor dissimilar 75-kDa subunit. 
Hucolin specifically elutes from HACA-Sepharose indicating 
it has a steroid-binding site. 
4. Discussion 
Ichijo et al. [12] partially purified a previously unidentified 
transforming rowth factor-ill binding protein from porcine 
uterus that had a disulphide-linked multimeric structure, 
formed of subunits of MW 40-kDa. Upon cloning the gene they 
identified fibrinogen- and collagen-like domains from the DNA 
sequence, and consequently named it ficolin [12]. They later 
expressed the 40-kDa ficolin subunit and found it spontane- 
ously formed multimers which were sensitive to reducing 
agents. The recombinant ficolin, however, did not bind TGF-Il l  
and they suggested an unidentified issimilar subunit could be 
required for binding activity. In addition they found porcine 
ficolin cDNA probes hybridised with human mRNA and con- 
cluded that the genes for a- and il-ficolin are 'strongly con- 
served between pig and human' [12]. 
Hucolin is a candidate for the conserved 'human ficolin' gene 
product as it shares a highly conserved N-terminal sequence 
with the ficolins and a similar disulphide-linked multimeric 
structure comprising, predominately, a 35-kDa subunit. In ad- 
dition, the 75-kDa subunit of hucolin could represent an equiv- 
alent of the dissimilar ficolin subunit postulated by Ichijo et al. 
[12]. However, we have no evidence that the dissimilar subunit 
of the hucolin complex is required for its cortisol-binding and 
further characterisation f this subunit was precluded by its low 
concentration. 
The N-terminus of a- and fl-ficolin was predicted by Ichijo 
et al. [12] from the cDNA gene sequence and on this basis 
hucolin would have a six amino acid N-terminal extension with 
respect o the porcine ficolins (Table 1). Conservation of the 
predicted pre-peptide cleavage site (threonine-cysteine) be- 
tween the ficolins and hucolin and the absence of cleavage of 
hucolin at this site suggests the true N-terminus of the ficolins 
may be more proximal. 
Another candidate for the human ficolin gene product has 
recently been identified [13]. Harumiya et al. [13] report the 
purification of EBP-37, a novel elastin-binding protein from 
human plasma nd presented 45 residues of exclusively internal 
amino acid sequence that included collagen like domains. This 
protein exhibited greater than 72% direct amino acid sequence 
identity with porcine ficolins. The largest continuous equence 
presented was a 15 amino acid lysyl endopeptidase cleavage 
fragment. EBP-37 also has a disulphide-linked multimeric 
Table 1 
Amino acid sequence homology between hucolin and porcine ficolins 
a and fl 
* 5 I0 * 15 20 * 25 
hucolin LQAAD TCPEV KMVGL EGSDK LT ILR  
fl-ficolin aqaad tCPEV KVVGL EGSDK LS ILR  
~-ficolin apa ld  tCPEV KVVGL EGSDK LS ILR  
Human S-gal WGS PSAQD EASPL  
Lower case denotes the predicted ficolin signal sequence and asterisks 
mark residues of hucolin that are not shared by ~-ficolin. The sequence 
from the spliced variant of human fl-galactosidase (Human S-gal) [14] 
illustrates an elastin binding site and is aligned with the predicted 
homologous region of the ficolins [13]. 
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Fig. 2. Concentrated samples of the minor elution peak of the HACA- 
Sepharose column were separated by 9% SDS-PAGE (a) without reduc- 
tion and (b) by two-dimensional 9% SDS-PAGE separation without 
reduction i  the 1st dimension and with reduction (2% 2-mercaptoetha- 
nol for 45 rain prior to separation) inthe 2nd. Spots were cut out and 
subjected toN-terminal sequence analysis. 
structure similar to both hucolin and the ficolins, with a similar 
subunit molecular weight of 37-kDa. 
Harumiya et al. [13] suggest, by homology with elastin-bind- 
ing proteins such as human fl-galactosidase, for which the 
elastin binding site sequence has been determined [14] (Table 
1), that the ficolins have an N-terminal elastin-binding region 
and predict hat the ficolin N-terminal elastin-binding domain 
will be conserved in EBP-37, however, no N-terminal sequence 
data for EBP-37 was presented. The N-terminal data presented 
here not only demonstrates the high degree of conservation f
the N-terminus between hucolin and the ficolins but supports 
the contention that hucolin has an elastin-binding site at the 
N-terminus and that hucolin and EBP-37 are identical or 
closely related proteins (Table 1). 
Speculation as to the in vivo role of the ficolins centres on 
their fibrinogen- and collagen-like domains that may modify or 
localise their TGF-fll-binding activity [12]. It has been sug- 
gested, for EBP-37, that its elastin-binding function may serve 
to localise it to the extracellular matrix of blood vessels and that 
its collagen-like domains may bind to the Clq receptor [13]. 
When the roles of these proteins are being considered the part 
played by a steroid-binding site should be included as this may 
be a common feature or function of the hucolin/EBP-37/ficolin 
group. TGF-fll has been shown to antagonise glucocorticoid 
induced impairment of wound healing [15] and it may be that 
the human ficolin gene product has a role in modulating anti- 
inflammatory glucocorticoids and growth inhibitors uch as 
TGF-fll where elastin is exposed in the arterial vessels by vas- 
cular disease. 
The N-terminal sequence information, provided by this in- 
vestigation, should aid the design of oligonucleotide probes to 
clone the gene for hucolin/EBP-37 by reverse PCR screening 
of human cDNA libraries. In addition HACA-chromatography 
may provide a step in an improved purification procedure for 
ficolins or hucolin/EBP-37 should they prove to be as highly 
conserved as these results uggest. 
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